EV Markers |
CD9 |
Cluster differentiation 9, Tetraspanin, endosomal membrane markers |
SN4/C3‐3A2 |
LifeSpan BioSciences, Lynnwood, WA, USA |
CD63 |
Cluster differentiation 63, Tetraspanin, endosomal membrane markers |
MEM‐259 |
Biolegend, San Diego, CA, USA |
CD81 |
Cluster differentiation 81 Tetraspanin, endosomal membrane markers |
1.3.3.22 |
LifeSpan BioSciences, Lynnwood, WA, USA |
CD82 |
Cluster differentiation 82 Tetraspanin, endosomal membrane markers |
|
|
Alix |
Apoptosis‐linked gene 2‐interacting protein X |
3A9 |
Biolegend, San Diego, CA, USA |
Integrins, immune and coagulation markers |
CD62E/P |
Endothelial/Platelet‐selectin, cell adhesion |
BBIG‐E(13D5) |
R&D system Inc., Minneapolis, MN, USA |
LFA1 |
Lymphocyte function‐associated antigen 1. |
HI111 |
Abbiotec, Inc., Escondido, CA, USA |
ICAM1 |
Intercellular Adhesion Molecule 1, cell adhesion |
R6.5 |
eBiosciences, San Diego, CA, USA |
VEGFR2 |
Vascular endothelial growth factor receptor 2, angiogenesis, vessel development and homeostasis |
7D4‐6 |
Biolegend, San Diego, CA, USA |
C1q |
Complement component 1q, recognition role in adaptive and innate immunity |
13A16, A201 |
Quidel‐Ortho Corporation, San Diego, CA, USA |
Glypican‐1 |
Heparan sulfate proteoglycan |
|
R&D system Inc., Minneapolis, MN, USA |
TNF RII |
Tumor necrosis factor Receptor II, immunomodulation |
22 210 |
R&D system Inc., Minneapolis, MN, USA |
Placental markers |
PLAP (1) |
Placental alkaline phosphatase |
8B6 |
Santa Cruz Biotechnologies, Dallas, TX, USA |
PLAP (2) |
Alkaline phosphatase specific to the placenta
5
|
NODGE |
Oxford group in house mAb |
PP13 (1) |
Specific placental galectin23, 24, 25
|
27‐3‐2 |
Hylabs, Rehovot, Israel |
PP13 (2) |
Specific placental galectin23, 24, 25
|
215‐28‐3 |
Hylabs, Rehovot, Israel |
PP13 (3) |
Specific placental galectin
24
|
534 |
Hylabs, Rehovot, Israel |